Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like Type 1 diabetes burden shifts: Higher prevalence but lower death rates in elderly June 17, 2024 Three new projects launched to map neuronal connections in the mouse and macaque brains September 26, 2023 High blood sugar at stroke admission linked to poor prognosis August 7, 2024
Three new projects launched to map neuronal connections in the mouse and macaque brains September 26, 2023